Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™

Autor: Julie Liberman, Pierre-Alexandre Bart, Laurent-Dominique Piveteau, Paul Vescovo, Reto Zanoni, Nirinarilala Ramaniraka, Astrid Cachemaille, Giuseppe Pantaleo, Nils Rettby, Karen Hart

Publikováno v: Vescovo, Paul; Rettby, Nils; Ramaniraka, Nirinarilala; Liberman, Julie; Hart, Karen; Cachemaille, Astrid; Piveteau, Laurent-Dominique; Zanoni, Reto Giacomo; Bart, Pierre-Alexandre; Pantaleo, Giuseppe (2017). Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™. Vaccine, 35(14), pp. 1782-1788. Elsevier 10.1016/j.vaccine.2016.09.069
Vaccine, vol. 35, no. 14, pp. 1782-1788

In a single-center study, 66 healthy volunteers aged between 18 and 50years were randomized to be immunized against rabies with three different injection routes: intradermal with DebioJect™ (IDJ), standard intradermal with classical needle (IDS), a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6df476e92d4c57a335f25b3a8519b3f
https://doi.org/10.1016/j.vaccine.2016.09.069